Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001209191-16-091686

Chief Executive Officer sold 2,400 shares at an average $20.20 ($48,468)

From the SEC's structured data for this filing

Trades in this filing

Ciechanover Isaac E. · Chief Executive Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2016-01-13 Sale : show line 1 in the form −1,200 $20.32 $24,384 380,411 I
2016-01-14 Sale : show line 2 in the form −1,200 $20.07 $24,084 379,211 I
Open-market sales · 2,400 sh · avg $20.20 · $48,468
Loading xslF345X03/doc4.xml…